These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8915820)

  • 1. Thrombopoietin: biology, clinical applications, role in the donor setting.
    Kuter DJ
    J Clin Apher; 1996; 11(3):149-59. PubMed ID: 8915820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin: Biology and Clinical Applications.
    Kuter DJ
    Oncologist; 1996; 1(1 & 2):98-106. PubMed ID: 10387974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical use of thrombopoietin (c-Mpl Ligand)].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human thrombopoietin: clinical experience and in vivo biology.
    Vadhan-Raj S
    Semin Hematol; 1998 Jul; 35(3):261-8. PubMed ID: 9685172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
    Lok S; Foster DC
    Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin: its role from early hematopoiesis to platelet production.
    Wendling F
    Haematologica; 1999 Feb; 84(2):158-66. PubMed ID: 10091415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of platelet growth factors in cancer therapy.
    Clarke K; Basser RL
    Stem Cells; 1996; 14 Suppl 1():274-80. PubMed ID: 11012231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
    Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
    Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
    Skotnicki AB; Jabłoński MJ
    Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biology of thrombopoietin and its receptors].
    Robak T
    Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin (Mpl-ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Thromb Haemost; 1997 Jul; 78(1):37-41. PubMed ID: 9198124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat.
    Yang C; Li YC; Kuter DJ
    Br J Haematol; 1999 May; 105(2):478-85. PubMed ID: 10233424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin: biology and potential clinical applications.
    Prow D; Vadhan-Raj S
    Oncology (Williston Park); 1998 Nov; 12(11):1597-604, 1607-8; discussion 1611-4. PubMed ID: 9834938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
    Begley CG
    Thromb Haemost; 1997 Jul; 78(1):42-6. PubMed ID: 9198125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
    Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Australian clinical studies with pegylated recombinant human megakaryocyte growth and development factor.
    Basser RL
    Stem Cells; 1998; 16 Suppl 2():225-9. PubMed ID: 11012194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
    Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
    Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.